A. Valipour (Vienna, Austria), A. Somfay (Szeged, Hungary)
The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure
P. Boschetto, A. Fucili, A. Potena, L. Ballerin, M. Stendardo, M. Simoni, G. Parrinello, L. M. Fabbri, C. Ceconi, R. Ferrari (Ferrara, Pisa, Brescia, Modena, Italy)
|   |
Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
N. Karoli, A. Rebrov (Russian Federation)
| |
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
N. Karoli, A. Rebrov (Russian Federation)
| |
Carotid atherosclerosis in COPD patients
A. Arsovska, Z. Arsovski, A. Popovski (Skopje, Fyrom)
| |
Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease
A. Ipatov, S. Panina, O. Soya, L. Volkova, N. Sanina (Dnopropetrovs'k, Ukraine)
| |
Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD
A. R. C. Patel, G. C. Donaldson, A. J. Mackay, J. J. P. Goldring, S. Karmali, J. A. Wedzicha, J. R. Hurst (United Kingdom)
| |
Hyperinflation associated with COPD is associated with impaired cardiac function and spontaneous baroreceptor sensitivity
V. Wieser, R. Breyer-Kohansal, I. Firlinger, I. Franke, O. Burghuber, A. Valipour (Vienna, Austria)
| |
Structural and biochemical characteristics of subclinical atherosclerosis in COPD
M. Urban, L. Cekici, G. C. Funk, M. Wolzt, O. C. Burghuber, A. Valipour (Vienna, Austria)
| |
Arterial stiffness in patients with COPD
N. Karoli, A. Rebrov (Russian Federation)
| |
COPD in heart failure patients
J. de Miguel Díez, M. Méndez Bailón, T. Gómez García, N. Muñoz Rivas, J. García Angulo, J. Ortiz Alonso, L. Puente-Maestu, L. Audibert Mena (Madrid, Spain)
| |
Implications of cardiovascular comorbidity and serum proadrenomedullin in dyspnoea scores in stable COPD
D. Stolz, K. Kostantinos, F. Blasi, J. Rakic, P. Castellotti, B. Milenkovic, W. Boersma, A. Lacoma, C. Prat, T. Welte, R. Louis, J. Aerts, A. Torres, E. Wouters, M. Tamm (Basel, Switzerland; Larissa, Greece; Milan, Italy; Belgrade, Republic Of Serbia; Breda, Maastricht, Netherlands; Badalona, Barcelona, Spain; Hannover, Germany; Liege, Belgium)
| |
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
G. Baimakanova, S. Avdeev, P. Zubairova, A. Chuchalin, K. Zykov, G. Tkachov (Moscow, Russian Federation)
| |
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
N. Karoli, A. Rebrov (Russian Federation)
| |
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
P. Fedotov, N. Shaporova, M. Sitnikova, N. Saphyanova, V. Iablonscaya, V. Dorofeykov, E. Shlyakhto (St. Petersberg, Russian Federation)
| |
Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
S. Baldi, G. Pinna, R. Maestri, U. Majani, M. Della Torre, T. Montagna, P. Crotti, E. Dacosto, S. Montemartini, A. De Martini, C. Fracchia, C. Bruschi (Pavia, Italy)
| |
Echocardiography based cardiac evaluation in the COPD patients suffered from the Chornobyl catastrophe
V. Sushko, O. Apostolova, L. Solovey (Kiev, Ukraine)
| |
Inflammatory cytokines of patients with peripheral arterial disease and COPD
K. Wozniak, J. Sleszycka, A. Safianowska, W. Wiechno, J. Domagala-Kulawik (Poland)
| |